Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Trifluridine/Tipiracil in Triple Negative Metastatic Breast Cancer (TACTIC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04149444
Recruitment Status : Withdrawn (Sponsor withdrew support)
First Posted : November 4, 2019
Last Update Posted : June 11, 2020
Sponsor:
Collaborator:
Tom Baker Cancer Centre
Information provided by (Responsible Party):
AHS Cancer Control Alberta

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : June 9, 2020
Actual Study Completion Date : June 9, 2020